{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_17756", "batch_size": 260, "batch_pos": 161, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment uses neutral language without high-potency verbs or metaphors.", "method": "llm_batch", "batch_id": "batch_2_18336", "batch_size": 260, "batch_pos": 149, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "The segment provides factual reporting without using a moderate verb paired with significant scale or impact.", "method": "llm_batch", "batch_id": "batch_3_7608", "batch_size": 260, "batch_pos": 120, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_16968", "batch_size": 260, "batch_pos": 115, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment reports a business fact neutrally, without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_17256", "batch_size": 260, "batch_pos": 114, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser used with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_6652", "batch_size": 260, "batch_pos": 103, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment states the company 'can confirm we are in discussions', not a bare negation of risk or impact.", "method": "llm_batch", "batch_id": "batch_7_9496", "batch_size": 260, "batch_pos": 102, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "Describes discussions about advancing a vaccine candidate ('in discussions... on advancing our pandemic flu candidate') without linking it to reassurance.", "method": "llm_batch", "batch_id": "batch_8_16600", "batch_size": 260, "batch_pos": 77, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
